Notice: Prescription Drug List (PDL): Multiple Additions (2021-10-21)
The purpose of this Notice of Amendment is to notify of the addition of the following medicinal ingredients on the Prescription Drug List (PDL) for human and veterinary use: Infigratinib or its salts, Lurbinectedin or its salts or derivatives, Pemigatinib or its salts, Propylthiouracil or its salts, Sacituzumab govitecan, and Sotorasib.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Notice: Prescription Drug List (PDL): Multiple Additions (2021-10-21)HTMLEnglish publication HTML
-
Notice: Prescription Drug List (PDL): Multiple Additions (2021-10-21)HTMLFrench publication HTML
Similar records